SCiAN CEO accepts invitation to attend workshop on the use of isoquercetin in response to Ebola in the Democratic Republic of Congo (DRC)


PHILADELPHIA, PA – October 21st, 2019 – Miklos Schulz, CEO of SCiAN Services will be attending a two-day workshop on October 23 & 24 in Montreal  to discuss the use of isoquercetin in the treatment of Ebola in the Democratic Republic of the Congo.

The workshop is hosted by the Montreal Clinical Research Institute and  individuals invited from the government, academic and private sectors will convene to discuss new measures to treat and prevent the Ebola virus disease.

“The Ebola outbreak continues to be a global health crisis.” said Dr. Miklos Schulz, CEO. “I am honoured to be a member of the working group that will focus on developing protocols and ethics guidelines for this new treatment strategy.”

 About SCiAN

SCiAN Services is a leading contract research organization (CRO) providing customized clinical trial services for clinical-stage start-ups and mid-size biotechnology companies.

For clinical-stage start-ups, we set-up, manage and execute all study activities from trial design, regulatory filing, trial management, DSMB, safety/DSUR updates, pharmacovigilance, data management, biostatistics and medical writing.

For mid-size bio-pharma companies, we offer large-scale biostatistics, statistical programming and data management services with high quality standards, timelines and deliverables maintained throughout the trial.

With 30+ years of experience in IND stage clinical trials and 690 studies completed, SCiAN’s therapeutic area expertise includes immune-oncology, oncology, CNS, infectious diseases, inflammatory / autoimmune diseases and diabetes.

For more information, please contact:

Jasna Szwagiel
Corporate Communication

Head Office
2150 Islington Avenue,
Suite 200
Toronto, ON, M9P 3V4

Ph: 416 231 8008
Fx: 416 416 231 1422

3675 Market Street,
6th Floor
Philadelphia, PA 19104

Ph: 267-244-8288

2950 Buskirk Ave,
Walnut Creek, CA 94597

Ph: 925-407-2069
Fx: 925-407-4769